1025 related articles for article (PubMed ID: 34818068)
1. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
Takamatsu Y; Imai M; Maeda K; Nakajima N; Higashi-Kuwata N; Iwatsuki-Horimoto K; Ito M; Kiso M; Maemura T; Takeda Y; Omata K; Suzuki T; Kawaoka Y; Mitsuya H
J Virol; 2022 Feb; 96(4):e0155121. PubMed ID: 34818068
[TBL] [Abstract][Full Text] [Related]
2. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
Imai M; Iwatsuki-Horimoto K; Hatta M; Loeber S; Halfmann PJ; Nakajima N; Watanabe T; Ujie M; Takahashi K; Ito M; Yamada S; Fan S; Chiba S; Kuroda M; Guan L; Takada K; Armbrust T; Balogh A; Furusawa Y; Okuda M; Ueki H; Yasuhara A; Sakai-Tagawa Y; Lopes TJS; Kiso M; Yamayoshi S; Kinoshita N; Ohmagari N; Hattori SI; Takeda M; Mitsuya H; Krammer F; Suzuki T; Kawaoka Y
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16587-16595. PubMed ID: 32571934
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma.
Maeda K; Higashi-Kuwata N; Kinoshita N; Kutsuna S; Tsuchiya K; Hattori SI; Matsuda K; Takamatsu Y; Gatanaga H; Oka S; Sugiyama H; Ohmagari N; Mitsuya H
Sci Rep; 2021 Mar; 11(1):5563. PubMed ID: 33692457
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters.
Su W; Sia SF; Schmitz AJ; Bricker TL; Starr TN; Greaney AJ; Turner JS; Mohammed BM; Liu Z; Choy KT; Darling TL; Joshi A; Cheng KM; Wong AYL; Harastani HH; Nicholls JM; Whelan SPJ; Bloom JD; Yen HL; Ellebedy AH; Boon ACM
mBio; 2021 Oct; 12(5):e0239521. PubMed ID: 34517754
[TBL] [Abstract][Full Text] [Related]
5. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model.
Haagmans BL; Noack D; Okba NMA; Li W; Wang C; Bestebroer T; de Vries R; Herfst S; de Meulder D; Verveer E; van Run P; Lamers MM; Rijnders B; Rokx C; van Kuppeveld F; Grosveld F; Drabek D; Geurts van Kessel C; Koopmans M; Bosch BJ; Kuiken T; Rockx B
J Infect Dis; 2021 Jun; 223(12):2020-2028. PubMed ID: 34043806
[TBL] [Abstract][Full Text] [Related]
7. Use of convalescent serum reduces severity of COVID-19 in nonhuman primates.
Cross RW; Prasad AN; Borisevich V; Woolsey C; Agans KN; Deer DJ; Dobias NS; Geisbert JB; Fenton KA; Geisbert TW
Cell Rep; 2021 Mar; 34(10):108837. PubMed ID: 33662255
[TBL] [Abstract][Full Text] [Related]
8. Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma.
Inada M; Togano T; Terada M; Shiratori K; Tsuzuki S; Takamatsu Y; Saito S; Hangaishi A; Morioka S; Kutsuna S; Maeda K; Mitsuya H; Ohmagari N
Transfus Apher Sci; 2023 Jun; 62(3):103638. PubMed ID: 36610860
[TBL] [Abstract][Full Text] [Related]
9. Convalescent plasma treatment of critically ill intensive care COVID-19 patients.
Lindemann M; Lenz V; Knop D; Klump H; Alt M; Aufderhorst UW; Schipper L; Schwarzkopf S; Meller L; Steckel N; Koldehoff M; Heinold A; Heinemann FM; Fischer J; Hutschenreuter G; Knabbe C; Dolff S; Brenner T; Dittmer U; Witzke O; Herbstreit F; Horn PA; Krawczyk A
Transfusion; 2021 May; 61(5):1394-1403. PubMed ID: 33784412
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin.
Volk A; Covini-Souris C; Kuehnel D; De Mey C; Römisch J; Schmidt T
BioDrugs; 2022 Jan; 36(1):41-53. PubMed ID: 34843105
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Infection of Rhesus Macaques Treated Early with Human COVID-19 Convalescent Plasma.
Deere JD; Carroll TD; Dutra J; Fritts L; Sammak RL; Yee JL; Olstad KJ; Reader JR; Kistler A; Kamm J; Di Germanio C; Shaan Lakshmanappa Y; Elizaldi SR; Roh JW; Simmons G; Watanabe J; Pollard RE; Usachenko J; Immareddy R; Schmidt BA; O'Connor SL; DeRisi J; Busch MP; Iyer SS; Van Rompay KKA; Hartigan-O'Connor DJ; Miller CJ
Microbiol Spectr; 2021 Dec; 9(3):e0139721. PubMed ID: 34817208
[TBL] [Abstract][Full Text] [Related]
12. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
13. Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters.
King HAD; Dussupt V; Mendez-Rivera L; Slike BM; Tran U; Jackson ND; Barkei E; Zemil M; Tourtellott-Fogt E; Kuklis CH; Soman S; Ahmed A; Porto M; Kitajewski C; Spence B; Benetiene D; Wieczorek L; Kar S; Gromowski G; Polonis VR; Krebs SJ; Modjarrad K; Bolton DL
Front Immunol; 2023; 14():1138629. PubMed ID: 37026013
[TBL] [Abstract][Full Text] [Related]
14. Predictive Analysis of the Neutralization Activity in Convalescent Plasmas From COVID-19 Recovered Patients in Zhejiang Province, China, January-March, 2020.
Yuan Y; Yu L; Jin Z; Wang Y; Gao M; Ding H; Zhuo X; Zhu X; Gao F; Zheng X; Ying G; Xu X; Kong Q; Lu S; Lv H
Front Cell Infect Microbiol; 2021; 11():650487. PubMed ID: 33796489
[TBL] [Abstract][Full Text] [Related]
15. Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation.
Van Rompay KKA; Olstad KJ; Sammak RL; Dutra J; Watanabe JK; Usachenko JL; Immareddy R; Roh JW; Verma A; Shaan Lakshmanappa Y; Schmidt BA; Di Germanio C; Rizvi N; Liu H; Ma ZM; Stone M; Simmons G; Dumont LJ; Allen AM; Lockwood S; Pollard RE; Ramiro de Assis R; Yee JL; Nham PB; Ardeshir A; Deere JD; Jain A; Felgner PL; Coffey LL; Iyer SS; Hartigan-O'Connor DJ; Busch MP; Reader JR
PLoS Pathog; 2022 Apr; 18(4):e1009925. PubMed ID: 35443018
[TBL] [Abstract][Full Text] [Related]
16. Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2-Infected Hamsters.
Carroll TD; Wong T; Morris MK; Di Germanio C; Ma ZM; Stone M; Ball E; Fritts L; Rustagi A; Simmons G; Busch M; Miller CJ
J Infect Dis; 2024 Jun; 229(6):1702-1710. PubMed ID: 38213276
[TBL] [Abstract][Full Text] [Related]
17. The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum.
Lu L; Chu AW; Zhang RR; Chan WM; Ip JD; Tsoi HW; Chen LL; Cai JP; Lung DC; Tam AR; Yau YS; Kwan MY; To WK; Tsang OT; Lee LL; Yi H; Ip TC; Poon RW; Siu GK; Mok BW; Cheng VC; Chan KH; Yuen KY; Hung IF; To KK
EBioMedicine; 2021 Sep; 71():103544. PubMed ID: 34419925
[TBL] [Abstract][Full Text] [Related]
18. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW
J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540
[TBL] [Abstract][Full Text] [Related]
19. The Relationship Between SARS-CoV-2 Neutralizing Antibody Titers and Avidity in Plasma Collected From Convalescent Nonvaccinated and Vaccinated Blood Donors.
Nurmi V; Knight C; Estcourt L; Hepojoki J; Lamikanra AA; Tsang HP; Roberts DJ; Polack FP; Simmonds P; Hedman K; Alvarez-Paggi D; Harvala H
J Infect Dis; 2023 Aug; 228(3):245-250. PubMed ID: 36967714
[TBL] [Abstract][Full Text] [Related]
20. Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples.
Bennett RS; Postnikova EN; Liang J; Gross R; Mazur S; Dixit S; Kocher G; Yu S; Georgia-Clark S; Gerhardt D; Cai Y; Marron L; Lukin VV; Holbrook MR
Viruses; 2021 May; 13(5):. PubMed ID: 34065987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]